MeAgain vs Gleva: The Broadest All-in-One

The pitch, and the catch

MeAgain is the broadest GLP-1 tracker on the market. Shots or pills, food logging, side effects, weight, progress and an AI companion, all in one place. It carries a 4.8 rating from roughly 25,000 App Store ratings, so a lot of people are getting on with it.

The free tier is more generous than its reputation suggests. Shot logging, side effects across 18 common symptoms plus custom ones, food logging, protein and water targets and a weight trend are all included without paying. Premium, around $10 a month, buys photo food logging, Journey Cards, the widget and unlimited AI chat.

That puts it in the same position as Shotsy, Glapp and GlucoPal: you can run the core tracking for as long as you like before deciding whether the paid tier is worth it. For a category where the real test is whether you are still logging in week ten, being able to find that out for free matters more than the headline price.

Feature by feature

Where breadth genuinely helps

The case for an all-in-one is real, and it is the one thing running two apps cannot solve.

If your food data is in MyFitnessPal and your dose data is in a tracker, the question that matters most — what does my intake actually do across the shot cycle — is answerable only by opening both and comparing by eye. People do that once and then stop. We make the same point in the MyFitnessPal comparison, and it is not a small gap.

Putting intake and injections on one timeline closes it. If protein on the days after a shot is your live concern — and it is a common one, covered in protein targets on GLP-1 — an all-in-one is the straightforward answer.

Where breadth costs

More surface means more logging, and more logging is the single most reliable predictor of abandonment. The tracking system that survives month three is almost always the smaller one.

So the question to ask before paying is not "would I like all of this" — everyone would — but "which of these will I still be filling in during week ten". If the honest answer is doses and symptoms, you are buying breadth you will not use, and a narrower free option will serve you better.

Data syncs to the cloud, as with most of the category.

Side by side

	MeAgain	Gleva
Available	Yes	No — in development
Free tier	Free core	—
Breadth	Widest in category	Deliberately narrow
Food logging	Yes, with AI	Not planned as a diary
AI companion	Yes	No
Storage	Cloud	Local-first, planned

Where we differ

We are building the opposite bet.

MeAgain's premise is that more of your life in one app produces a better picture. Ours is that the picture fails for a different reason — not missing data, but unread data. By month three most people have doses, side effects, weights and notes, and still cannot answer whether the nausea tracks the dose or the meals.

So we are building for interpretation over capture: fewer fields, more surfaced about what the fields already say. That is a narrower product with a sharper claim, and MeAgain has the advantage of existing.

How to choose

Choose MeAgain if you want one app for treatment and food, and you will actually use the breadth. Run the free tier for a few weeks first — it covers enough to tell you whether you will.

Choose a narrower tracker if the breadth is the part you doubt. Shotsy, Glapp and GlucoPal all have free core tracking with a smaller surface — see the full comparison.

Wait for Gleva if your problem is interpretation rather than coverage.

MeAgain is a trademark of its respective owner. Gleva is not affiliated with, endorsed by or sponsored by it. Pricing and features change — confirm on the store listing. Nothing here is medical advice.